AOD-9604
HGH fragment targeting fat metabolism without IGF-1 side effects.
300 mcg/day
Key Benefits
activates lipolysis in adipose tissue without systemic HGH side effects
safe metabolic profile confirmed in clinical trials
preclinical data shows regenerative effects on joint tissue
blocks new fat storage at the cellular level
Recommended Injection Sites
Optimal injection locations for AOD-9604 based on its route (Subcutaneous injection) and pharmacokinetic profile.
Tap a glowing zone on the body map to highlight the matching site card — or tap a card to activate the zone.
Tap a zone to inject
Preferred for metabolic peptides. Rotate quadrants.
Reliable alternative site.
Rotate injection sites to prevent lipodystrophy.
- IV administration
- Intramuscular injection
Active Signaling Pathway
Recommended Stacks
AOD-9604 is a key compound in these curated research stacks. Pair it with synergistic peptides for enhanced outcomes.
Metabolic Reset Protocol
Next-generation GLP-1 + amylin combination for advanced weight management research.
How long will one vial last?
Based on standard research protocols, here's exactly what to expect from a single 5mg vial — and when to plan your next order.
Actual duration may vary based on your specific protocol. Always consult your research guidelines for precise dosing schedules.
Scientific Background
Mechanism of Action
AOD-9604 mimics the lipolytic domain of hGH by binding fat cell receptors and activating beta-3 adrenergic pathways. It stimulates breakdown of stored triglycerides (lipolysis) while simultaneously blocking new fat formation (lipogenesis), without activating the IGF-1 axis or causing insulin resistance.
Clinical Context
AOD-9604 was originally developed by Monash University as an anti-obesity drug. Its clean safety profile and targeted fat-loss mechanism make it one of the most studied metabolic peptides in clinical settings.
Research Highlights
- Phase IIb/III clinical trials demonstrated significant reduction in body fat in obese subjects over 12 weeks
- Does not affect blood glucose or insulin sensitivity — key safety advantage over full HGH
- Shown to stimulate cartilage and bone repair in preclinical models
- FDA GRAS (Generally Recognized As Safe) designation obtained in 2014
Storage & Reconstitution
Store lyophilized at -20°C. Reconstitute with 1 mL bacteriostatic water → 5 mg/mL. On a 100-unit insulin syringe, 1 unit = 50 mcg. Stable 4 weeks at 2–8°C after reconstitution.
Best administered fasted. Typical research cycle: 12 weeks.